Related content

Genetic polymorphisms of human flavin-containing monooxygenase 3: implications for drug metabolism and clinical perspectives

By Hisamuddin Irfan M   Yang Vincent W  

Pharmacogenomics, Vol. 8, Iss. 6, 2007-06 ,pp. : 635-643

Future Medicine

Access to resources Recommend Favorite

Flavin-containing monooxygenase 3 and human disease

By Motika Meike S   Zhang Jun   Cashman John R  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 3, Iss. 6, 2007-12 ,pp. : 831-845

Informa Healthcare

Access to resources Recommend Favorite

Biochemical and Clinical Aspects of the Human Flavin-Containing Monooxygenase Form 3 (FMO3) Related to Trimethylaminuria

By  

Current Drug Metabolism, Vol. 4, Iss. 2, 2003-04 ,pp. : 151-170

Bentham Science Publishers

Access to resources Recommend Favorite

Flavin-containing monooxygenase genetic polymorphism: impact on chemical metabolism and drug development

By Koukouritaki Sevasti B   Hines Ronald N  

Pharmacogenomics, Vol. 6, Iss. 8, 2005-12 ,pp. : 807-822

Future Medicine

Access to resources Recommend Favorite

Human Flavin-Containing Monooxygenase Substrate Specificity and Role in Drug Metabolism

By  

Current Drug Metabolism, Vol. 1, Iss. 2, 2000-09 ,pp. : 181-191

Bentham Science Publishers

Access to resources Recommend Favorite